Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
-
- KURODA Junya
- Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
-
- KAMITSUJI Yuri
- Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
-
- KIMURA Shinya
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- ASHIHARA Eishi
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- KAWATA Eri
- Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
-
- NAKAGAWA Yoko
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- TAKEUICHI Miki
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- MUROTANI Yoshihide
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- YOKOTA Asumi
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- TANAKA Ruriko
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
-
- ANDREEFF Michael
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, M. D. Anderson Cancer Center
-
- TANIWAKI Masafumi
- Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine
-
- MAEKAWA Taira
- Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital
この論文をさがす
収録刊行物
-
- International journal of hematology
-
International journal of hematology 87 (5), 507-515, 2008-06-15
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1571980075509764736
-
- NII論文ID
- 10021256497
-
- NII書誌ID
- AA10797094
-
- ISSN
- 09255710
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles